Neo Modulus Secures $40.9M Series C Funding for Regenerative Medical Devices
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd., a prominent developer of regenerative implantable medical devices...
Finance
Ouro Medicines Launches with $120M Series A Financing for CM336 Development
Ouro Medicines, the licensee of China-based Keymed Biosciences Inc.’s (HKG: 2162) CM336, has successfully launched...
Shenzhen Oculgen Secures Over RMB 100 Million in Series A Funding
Shenzhen Oculgen Biomedical Technology Co., Ltd. has successfully completed a Series A financing round, raising...
Keymed Biosciences Licenses CM313 to Timberlyne Therapeutics for Global Development
China-based Keymed Biosciences Inc. (HKG: 2162) has entered into a licensing agreement with US firm...
Immunochina Pharmaceuticals Raises Series E Funding for CAR-T Therapy IM19
Beijing-based biotech Immunochina Pharmaceuticals has reportedly raised “hundreds of millions” of renminbi in a Series...
Danaher Corporation Partners with Innovaccer to Enhance Healthcare AI Solutions
US-based science and tech services giant Danaher Corporation (NYSE: DHR) has announced an investment partnership...
Verdiva Bio Launches with USD 411 Million Series A Financing for Biopharma Development
UK-based Verdiva Bio Limited has announced its launch as a clinical-stage biopharma company, backed by...
Stryker to Acquire Inari Medical for USD 4.9 Billion to Boost VTE Pipeline
US-based Stryker (NYSE: SYK) has reached a definitive acquisition agreement with compatriot firm Inari Medical,...
Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has reportedly raised USD 100 million in...
Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
US major Boston Scientific Corporation (NYSE: BSX) is set to acquire Bolt Medical, Inc., a...
LinkedCare Raises Hundreds of Millions in Series E Funding Led by State-Owned Investors
LinkedCare, a consumer healthcare SaaS+ supply chain platform based in Shanghai, has reportedly raised “hundreds...
Alebund Pharmaceuticals Completes Series C Financing to Advance Kidney Disease Pipelines
Shanghai-based Alebund Pharmaceuticals has announced the completion of a Series C financing round, raising RMB...
Shengwei Kunteng Raises RMB 200 Million in Series A Financing for POCT Development
China-based Hunan Shengwei Kunteng Biotechnology Co., Ltd has announced that it has raised close to...
Hangzhou Highlightll Pharma Completes Pre-Series C Financing Round
China-based Hangzhou Highlightll Pharmaceutical Co., Ltd has announced the successful completion of a Pre-Series C...
Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding
Milestone Biotechnologies, a leading biotechnology company based in Shanghai, has announced the completion of a...
Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
Beijing-based Prime Gene Therapeutics Co., Ltd (873969.NQ), a clinical-stage biotech company specializing in immune inflammatory...
Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing
Immunotherapy biotech company Maxvax Biotechnology, based in Chengdu, has announced the successful closure of a...
Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion
China’s Shinva Medical Instrument Co., Ltd (SHA: 600587) has announced its intention to acquire a...
Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion
Reforgene Medicine, a prominent gene editing therapy company headquartered in Guangzhou, has reportedly secured hundreds...
GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities
On December 27, 2024, GenFleet Therapeutics, a biopharmaceutical company based in Shanghai, submitted its application...